The Valley Desk

Clinical trial reportHeadachePublished

Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Jefferson Health. Affiliation source

Institution
Jefferson Health

Publication record

Type
Clinical trial report
Venue
Headache
Published
Subject terms
Humans; Headache; Treatment Outcome; Double-Blind Method; Adult; Migraine Disorders; Headache Disorders, Secondary; Antibodies, Monoclonal, Humanized; Health-related Quality Of Life; Patient-reported Outcomes; Medication-overuse Headache; Eptinezumab
PubMed ID
36633219
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal